Ischemia-modified albumin and advanced oxidation protein products as potential biomarkers of protein oxidation in Alzheimer's disease
GERIATRICS & GERONTOLOGY INTERNATIONAL, cilt.15, sa.7, ss.872-880, 2015 (SCI-Expanded, SSCI, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 15 Sayı: 7
- Basım Tarihi: 2015
- Doi Numarası: 10.1111/ggi.12361
- Dergi Adı: GERIATRICS & GERONTOLOGY INTERNATIONAL
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Social Sciences Citation Index (SSCI), Scopus
- Sayfa Sayıları: ss.872-880
- Anahtar Kelimeler: advanced oxidation protein products, Alzheimer's disease, ischemia-modified albumin, oxidative stress, prooxidant-antioxidant balance, STRESS MARKERS, BALANCE, DAMAGE, WOMEN
- İstanbul Üniversitesi-Cerrahpaşa Adresli: Evet
Özet
BackgroundThe aim of the present study was to determine the systemic levels of oxidative stress markers, such as ischemia-modified albumin (IMA), advanced oxidation protein products (AOPP), ferric reducing antioxidant power (FRAP) and the prooxidant-antioxidant balance (PAB), to clarify protein redox homeostasis in patients with Alzheimer's disease, and to compare them with mentally healthy persons of the same age.